[A double-blind study on the effect of dexetimide in the control of neuroleptic-induced extrapyramidal side-effects].
A double-blind study was carried out on the therapeutic effects of dexetimide and artane in the control of neuroleptic-induced extrapyramidal side-effects in 261 cases of schizophrenia. The authors found that therapeutic effects of two drugs for the control of extrapyramidal signs were equal. Dexetimidal had the advantages of less side-effects, less dosage and long-action.
Chen
Y
Y
Mental Health Institute of Hunan Medical University, Changsha.
D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D003909:Dexetimide / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy; D014282:Trihexyphenidyl / Q000627:therapeutic use
D014150:Antipsychotic Agents; D003909:Dexetimide; D014282:Trihexyphenidyl